Clinical Trial Update: Intra-venous Zoledronic Acid Once Yearly

View source ↗

Summary

This document notes the completion of a clinical trial evaluating annual intravenous zoledronic acid for postmenopausal osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Post-Menopausal Osteoporosis | Status: COMPLETED